TRIFLUOPERAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Acceptability of treatment ‐ leaving the study early · patients with schizophrenia
Trifluoperazine showed no clear difference in leaving the study early: 1. Acceptability of treatment ‐ leaving… compared with low‐potency antipsychotic drugs (low certainty).
1 finding from 1 review
- Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 1.25 [0.72, 2.17]3 studies · 239 participantsLow